Stock Market Reviews

Read and share opinions on CBLL (CeriBell, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
  Nov 6, 2025
• CeriBell (CBLL): Revenue Growth Forecast at 23.4% Drives High Valuation Despite Losses
  Nov 6, 2025
• CeriBell Inc (CBLL) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
  Nov 5, 2025
• CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates
  Nov 4, 2025
• Ceribell Reports Third Quarter 2025 Financial Results
  Nov 4, 2025
• CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy?
  Oct 28, 2025
• Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
  Oct 21, 2025
• Medtech Leader Erica Rogers Joins Ceribell Board of Directors
  Sep 22, 2025
• J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT
  Aug 13, 2025
• CeriBell Second Quarter 2025 Earnings: Beats Expectations
  Aug 7, 2025
• Ceribell Reports Second Quarter 2025 Financial Results
  Aug 5, 2025
• Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
  Jul 29, 2025
• Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
  Jul 22, 2025
• Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
  Jul 7, 2025
• Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
  May 20, 2025
• US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results
  May 11, 2025